15-12B

CRH MEDICAL CORPORATION

Date: May 4, 2021

/s/ Richard Bear

Name: Richard Bear

Title: Chief Financial Officer

15-12B 1 d145412d1512b.htm 15-12B 15-12B

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-37542

CRH MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

Suite 619 – 999 Canada Place, World Trade Center

Vancouver, BC V6C 3E1

(604) 633-1440

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Shares, no par value

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


		Rule 12g-4(a)(1)		☒
		Rule 12g-4(a)(2)		☐
		Rule 12h-3(b)(1)(i)		☒
		Rule 12h-3(b)(1)(ii)		☐
		Rule 15d-6		☐
		Rule 15d-22(b)		☐

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, CRH Medical Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

SEC Form 15-12B filed by CRH Medical Corporation